Sphingosine 1-phosphate

Sphingosine 1-phosphate is a lipid of Sphingolipids (SP) class. Sphingosine 1-phosphate is associated with abnormalities such as Infection, Painful Bladder Syndrome, Atherosclerosis, Hyperglycemia and Rheumatoid Arthritis. The involved functions are known as Phosphorylation, Regulation, enzyme activity, Energy Absorption and Vascular Permeability. Sphingosine 1-phosphate often locates in Endothelium, Tissue membrane, Vascular System, Protoplasm and Microfilaments. The associated genes with Sphingosine 1-phosphate are MBTPS1 gene, FBXL15 gene, TEK gene, NTRK1 gene and Gene Family. The related lipids are Promega, Lipopolysaccharides, lysophosphatidic acid, Lysophosphatidylcholines and Lysophospholipids. The related experimental models are Knock-out, Mouse Model, Transgenic Model, Disease model and Experimental Autoimmune Encephalomyelitis.

Cross Reference

Introduction

To understand associated biological information of Sphingosine 1-phosphate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Sphingosine 1-phosphate?

Sphingosine 1-phosphate is suspected in Lymphopenia, Ischemia, Infection, Atherosclerosis, Multiple Sclerosis, Asthma and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Sphingosine 1-phosphate

MeSH term MeSH ID Detail
Coronary Disease D003327 70 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Leukemia D007938 74 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Atherosclerosis D050197 85 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Arteriosclerosis D001161 86 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Insulin Resistance D007333 99 associated lipids
Weight Gain D015430 101 associated lipids
Glioma D005910 112 associated lipids
Hypertension D006973 115 associated lipids
Inflammation D007249 119 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Hemolysis D006461 131 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Edema D004487 152 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Adenocarcinoma D000230 166 associated lipids
Per page 10 20 50 100 | Total 101

PubChem Associated disorders and diseases

What pathways are associated with Sphingosine 1-phosphate

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Sphingosine 1-phosphate through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Sphingosine 1-phosphate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Sphingosine 1-phosphate?

Knock-out

Knock-out are used in the study 'Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFkappaB-inducing kinase in stromal cells.' (Kunisawa J et al., 2008), Knock-out are used in the study 'Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells.' (Markiewicz M et al., 2011), Knock-out are used in the study 'Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival.' (Yang Q, 2007), Knock-out are used in the study 'Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function.' (Idzko M et al., 2006) and Knock-out are used in the study 'Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho.' (Gratzinger D et al., 2003).

Mouse Model

Mouse Model are used in the study 'Regulation of the micromechanical properties of pulmonary endothelium by S1P and thrombin: role of cortactin.' (Arce FT et al., 2008), Mouse Model are used in the study 'Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.' (Tengood JE et al., 2010), Mouse Model are used in the study 'S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells.' (Chang CL et al., 2009), Mouse Model are used in the study 'Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages.' (Hughes JE et al., 2008) and Mouse Model are used in the study 'The alliance of sphingosine-1-phosphate and its receptors in immunity.' (Rivera J et al., 2008).

Transgenic Model

Transgenic Model are used in the study 'Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.' (Augé N et al., 2004), Transgenic Model are used in the study 'Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.' (Sabbadini RA, 2011) and Transgenic Model are used in the study 'Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.' (Gault CR and Obeid LM, 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Sphingosine 1-phosphate

Download all related citations
Per page 10 20 50 100 | Total 2896
Authors Title Published Journal PubMed Link
Kang H et al. Fluid shear stress modulates endothelial cell invasion into three-dimensional collagen matrices. 2008 Am. J. Physiol. Heart Circ. Physiol. pmid:18805898
Wymann MP and Schneiter R Lipid signalling in disease. 2008 Nat. Rev. Mol. Cell Biol. pmid:18216772
Schüppel M et al. Sphingosine 1-phosphate restrains insulin-mediated keratinocyte proliferation via inhibition of Akt through the S1P2 receptor subtype. 2008 J. Invest. Dermatol. pmid:18219276
Tauseef M et al. Activation of sphingosine kinase-1 reverses the increase in lung vascular permeability through sphingosine-1-phosphate receptor signaling in endothelial cells. 2008 Circ. Res. pmid:18849324
Machida T et al. Sphingosine 1-phosphate inhibits nitric oxide production induced by interleukin-1beta in rat vascular smooth muscle cells. 2008 J. Pharmacol. Exp. Ther. pmid:18171908
Hinkovska-Galcheva V et al. The role of sphingosine-1-phosphate and ceramide-1-phosphate in calcium homeostasis. 2008 Curr Opin Investig Drugs pmid:18951299
Peest U et al. S1P-lyase independent clearance of extracellular sphingosine 1-phosphate after dephosphorylation and cellular uptake. 2008 J. Cell. Biochem. pmid:18172856
Asada S et al. Downregulation of Dicer expression by serum withdrawal sensitizes human endothelial cells to apoptosis. 2008 Am. J. Physiol. Heart Circ. Physiol. pmid:18978195
Liu Q et al. FTY720 demonstrates promising preclinical activity for chronic lymphocytic leukemia and lymphoblastic leukemia/lymphoma. 2008 Blood pmid:17761520
Kimura T et al. Induction of scavenger receptor class B type I is critical for simvastatin enhancement of high-density lipoprotein-induced anti-inflammatory actions in endothelial cells. 2008 J. Immunol. pmid:18981156
Stradner MH et al. Spingosine-1-phosphate stimulates proliferation and counteracts interleukin-1 induced nitric oxide formation in articular chondrocytes. 2008 Osteoarthr. Cartil. pmid:17703957
Wacker BK et al. Endothelial cell migration on RGD-peptide-containing PEG hydrogels in the presence of sphingosine 1-phosphate. 2008 Biophys. J. pmid:17827231
Moriue T et al. Sphingosine 1-phosphate attenuates H2O2-induced apoptosis in endothelial cells. 2008 Biochem. Biophys. Res. Commun. pmid:18267109
Malchinkhuu E et al. S1P(2) receptors mediate inhibition of glioma cell migration through Rho signaling pathways independent of PTEN. 2008 Biochem. Biophys. Res. Commun. pmid:18088600
Fortier S et al. Silencing of the MT1-MMP/ G6PT axis suppresses calcium mobilization by sphingosine-1-phosphate in glioblastoma cells. 2008 FEBS Lett. pmid:18267120
Kim HL et al. Characterization of N,N,-dimethyl-D-erythro-sphingosine-induced apoptosis and signaling in U937 cells: independence of sphingosine kinase inhibition. 2008 Prostaglandins Other Lipid Mediat. pmid:18316219
Huwiler A and Pfeilschifter J New players on the center stage: sphingosine 1-phosphate and its receptors as drug targets. 2008 Biochem. Pharmacol. pmid:18321471
Jo SK et al. Sphingosine-1-phosphate receptors: biology and therapeutic potential in kidney disease. 2008 Kidney Int. pmid:18322542
Hughes JE et al. Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages. 2008 Circ. Res. pmid:18323526
Li X et al. Basal and angiopoietin-1-mediated endothelial permeability is regulated by sphingosine kinase-1. 2008 Blood pmid:18199826
Sobue S et al. Implications of sphingosine kinase 1 expression level for the cellular sphingolipid rheostat: relevance as a marker for daunorubicin sensitivity of leukemia cells. 2008 Int. J. Hematol. pmid:18283525
Youm JK et al. K6PC-5, a sphingosine kinase activator, induces anti-aging effects in intrinsically aged skin through intracellular Ca2+ signaling. 2008 J. Dermatol. Sci. pmid:18420384
Li QF et al. Sphingosine 1-phosphate induces Mcl-1 upregulation and protects multiple myeloma cells against apoptosis. 2008 Biochem. Biophys. Res. Commun. pmid:18423379
Wu YP et al. Sphingosine kinase 1/S1P receptor signaling axis controls glial proliferation in mice with Sandhoff disease. 2008 Hum. Mol. Genet. pmid:18424450
Lavieu G et al. Sphingolipids in macroautophagy. 2008 Methods Mol. Biol. pmid:18425450
Miller AV et al. Sphingosine kinases and sphingosine-1-phosphate are critical for transforming growth factor beta-induced extracellular signal-regulated kinase 1 and 2 activation and promotion of migration and invasion of esophageal cancer cells. 2008 Mol. Cell. Biol. pmid:18426913
Igarashi J and Michel T The enigma of sphingosine 1-phosphate synthesis: a novel role for endothelial sphingosine kinases. 2008 Circ. Res. pmid:18369161
Gohda M et al. Sphingosine 1-phosphate regulates the egress of IgA plasmablasts from Peyer's patches for intestinal IgA responses. 2008 J. Immunol. pmid:18390715
Lichte K et al. Lysophospholipid receptor-mediated calcium signaling in human keratinocytes. 2008 J. Invest. Dermatol. pmid:18172456
Avery K et al. Sphingosine-1-phosphate mediates transcriptional regulation of key targets associated with survival, proliferation, and pluripotency in human embryonic stem cells. 2008 Stem Cells Dev. pmid:18393631
Eskan MA et al. TLR4 and S1P receptors cooperate to enhance inflammatory cytokine production in human gingival epithelial cells. 2008 Eur. J. Immunol. pmid:18395849
De Luca T et al. Downstream targets of altered sphingolipid metabolism in response to inhibition of ENOX2 by phenoxodiol. 2008 Biofactors pmid:19734127
Krump-Konvalinkova V et al. FTY720 inhibits S1P-mediated endothelial healing: relationship to S1P1-receptor surface expression. 2008 Biochem. Biophys. Res. Commun. pmid:18402775
Olivera A Unraveling the complexities of sphingosine-1-phosphate function: the mast cell model. 2008 Prostaglandins Other Lipid Mediat. pmid:18403224
Sefcik LS et al. Sustained release of sphingosine 1-phosphate for therapeutic arteriogenesis and bone tissue engineering. 2008 Biomaterials pmid:18405965
Arce FT et al. Regulation of the micromechanical properties of pulmonary endothelium by S1P and thrombin: role of cortactin. 2008 Biophys. J. pmid:18408039
Chung FY et al. Signaling mechanisms of sphingosine 1-phosphate-induced ERK1/2 activation in cultured feline esophageal smooth muscle cells. 2008 Arch. Pharm. Res. pmid:19023540
Pasquaré SJ et al. Involvement of lysophosphatidic acid, sphingosine 1-phosphate and ceramide 1-phosphate in the metabolization of phosphatidic acid by lipid phosphate phosphatases in bovine rod outer segments. 2008 Neurochem. Res. pmid:18288612
Jiang H et al. Distinguishing fibroblast promigratory and procontractile growth factor environments in 3-D collagen matrices. 2008 FASEB J. pmid:18272655
Valentine WJ et al. Subtype-specific residues involved in ligand activation of the endothelial differentiation gene family lysophosphatidic acid receptors. 2008 J. Biol. Chem. pmid:18316373
Borges S et al. Discrete influx events refill depleted Ca2+ stores in a chick retinal neuron. 2008 J. Physiol. (Lond.) pmid:18033816
Pederson L et al. Regulation of bone formation by osteoclasts involves Wnt/BMP signaling and the chemokine sphingosine-1-phosphate. 2008 Proc. Natl. Acad. Sci. U.S.A. pmid:19075223
Szczepaniak WS et al. Sphingosine 1-phosphate rescues canine LPS-induced acute lung injury and alters systemic inflammatory cytokine production in vivo. 2008 Transl Res pmid:19010292
Hsieh HL et al. Sphingosine 1-phosphate induces EGFR expression via Akt/NF-kappaB and ERK/AP-1 pathways in rat vascular smooth muscle cells. 2008 J. Cell. Biochem. pmid:17902169
Murakami M et al. Identification of the orphan GPCR, P2Y(10) receptor as the sphingosine-1-phosphate and lysophosphatidic acid receptor. 2008 Biochem. Biophys. Res. Commun. pmid:18466763
Balthasar S et al. Interactions between sphingosine-1-phosphate and vascular endothelial growth factor signalling in ML-1 follicular thyroid carcinoma cells. 2008 Endocr. Relat. Cancer pmid:18509004
Kohno T and Igarashi Y Attenuation of cell motility observed with high doses of sphingosine 1-phosphate or phosphorylated FTY720 involves RGS2 through its interactions with the receptor S1P. 2008 Genes Cells pmid:18513330
Miron VE et al. FTY720 modulates human oligodendrocyte progenitor process extension and survival. 2008 Ann. Neurol. pmid:17918267
Harvey KA et al. Trans-fatty acids induce pro-inflammatory responses and endothelial cell dysfunction. 2008 Br. J. Nutr. pmid:17925051
Takashima S et al. G12/13 and Gq mediate S1P2-induced inhibition of Rac and migration in vascular smooth muscle in a manner dependent on Rho but not Rho kinase. 2008 Cardiovasc. Res. pmid:18480127
Yatomi Y Plasma sphingosine 1-phosphate metabolism and analysis. 2008 Biochim. Biophys. Acta pmid:17980708
Rivera R and Chun J Biological effects of lysophospholipids. 2008 Rev. Physiol. Biochem. Pharmacol. pmid:18481029
Jang S et al. Changes in iNOS, GFAP and NR1 expression in various brain regions and elevation of sphingosine-1-phosphate in serum after immobilized stress. 2008 Neurochem. Res. pmid:17940874
Bu S et al. Opposite effects of dihydrosphingosine 1-phosphate and sphingosine 1-phosphate on transforming growth factor-beta/Smad signaling are mediated through the PTEN/PPM1A-dependent pathway. 2008 J. Biol. Chem. pmid:18482992
Gavrilovskaya IN et al. Hantaviruses direct endothelial cell permeability by sensitizing cells to the vascular permeability factor VEGF, while angiopoietin 1 and sphingosine 1-phosphate inhibit hantavirus-directed permeability. 2008 J. Virol. pmid:18367532
Zanin M et al. Trophic action of sphingosine 1-phosphate in denervated rat soleus muscle. 2008 Am. J. Physiol., Cell Physiol. pmid:17942639
Tölle M et al. HDL-associated lysosphingolipids inhibit NAD(P)H oxidase-dependent monocyte chemoattractant protein-1 production. 2008 Arterioscler. Thromb. Vasc. Biol. pmid:18483405
Huang YT et al. Sphingosine 1-phosphate induces platelet/endothelial cell adhesion molecule-1 phosphorylation in human endothelial cells through cSrc and Fyn. 2008 Cell. Signal. pmid:18502612
Chen LY et al. Cytosolic phospholipase A2alpha activation induced by S1P is mediated by the S1P3 receptor in lung epithelial cells. 2008 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:18502815
Wamhoff BR et al. Sphingosine-1-phosphate receptor subtypes differentially regulate smooth muscle cell phenotype. 2008 Arterioscler. Thromb. Vasc. Biol. pmid:18535287
Rapizzi E et al. Sphingosine 1-phosphate differentially regulates proliferation of C2C12 reserve cells and myoblasts. 2008 Mol. Cell. Biochem. pmid:18454302
Son DJ et al. Enhanced release of sphingosine-1-phosphate from hypercholesterolemic platelets: role in development of hypercholesterolemic atherosclerosis. 2008 Prostaglandins Leukot. Essent. Fatty Acids pmid:18571912
Swaney JS et al. Sphingosine-1-phosphate (S1P) is a novel fibrotic mediator in the eye. 2008 Exp. Eye Res. pmid:18687328
Zeidan YH et al. Molecular targeting of acid ceramidase: implications to cancer therapy. 2008 Curr Drug Targets pmid:18691012
Argraves KM et al. High density lipoprotein-associated sphingosine 1-phosphate promotes endothelial barrier function. 2008 J. Biol. Chem. pmid:18606817
González-Díez M et al. Prostacyclin induction by high-density lipoprotein (HDL) in vascular smooth muscle cells depends on sphingosine 1-phosphate receptors: effect of simvastatin. 2008 Thromb. Haemost. pmid:18612546
Jin YZ et al. Reciprocal function of Galphai2 and Galphai3 in graft-versus-host disease. 2008 Eur. J. Immunol. pmid:18521956
Lynch KR and Macdonald TL Sphingosine 1-phosphate chemical biology. 2008 Biochim. Biophys. Acta pmid:18638568
Igarashi J and Michel T S1P and eNOS regulation. 2008 Biochim. Biophys. Acta pmid:18638569
Machesky NJ et al. Human cytomegalovirus regulates bioactive sphingolipids. 2008 J. Biol. Chem. pmid:18644793
Pchejetski D et al. Chemosensitizing effects of sphingosine kinase-1 inhibition in prostate cancer cell and animal models. 2008 Mol. Cancer Ther. pmid:18644996
Zhao C et al. Specific and overlapping sphingosine-1-phosphate receptor functions in human synoviocytes: impact of TNF-alpha. 2008 J. Lipid Res. pmid:18658144
Rivera J et al. The alliance of sphingosine-1-phosphate and its receptors in immunity. 2008 Nat. Rev. Immunol. pmid:18787560
Jessup W Lipid metabolism: sources and stability of plasma sphingosine-1-phosphate. 2008 Curr. Opin. Lipidol. pmid:18769238
Rivera J et al. New insights on mast cell activation via the high affinity receptor for IgE. 2008 Adv. Immunol. pmid:18772004
Westerberg LS et al. WASP confers selective advantage for specific hematopoietic cell populations and serves a unique role in marginal zone B-cell homeostasis and function. 2008 Blood pmid:18772454
Huang WR et al. [SphK-1/S1P signal pathway in CML cells]. 2008 Zhongguo Shi Yan Xue Ye Xue Za Zhi pmid:18718048
Serrano-Sanchez M et al. Signaling pathways involved in sphingosine kinase activation and sphingosine-1-phosphate release in rat myometrium in late pregnancy: role in the induction of cyclooxygenase 2. 2008 Endocrinology pmid:18723875
Yan G et al. Activation of sphingosine kinase-1 mediates induction of endothelial cell proliferation and angiogenesis by epoxyeicosatrienoic acids. 2008 Cardiovasc. Res. pmid:18192241
Ullrich T et al. Synthesis and immobilization of erythro-C14-omega-aminosphingosine-1-phosphate as a potential tool for affinity chromatography. 2008 ChemMedChem pmid:18000941
Roelofsen T et al. Sphingosine-1-phosphate acts as a developmental stage specific inhibitor of platelet-derived growth factor-induced chemotaxis of osteoblasts. 2008 J. Cell. Biochem. pmid:18819098
Bryan L et al. Sphingosine-1-phosphate and interleukin-1 independently regulate plasminogen activator inhibitor-1 and urokinase-type plasminogen activator receptor expression in glioblastoma cells: implications for invasiveness. 2008 Mol. Cancer Res. pmid:18819934
Fulton D et al. Agonist-stimulated endothelial nitric oxide synthase activation and vascular relaxation. Role of eNOS phosphorylation at Tyr83. 2008 Circ. Res. pmid:18096817
Strochlic L et al. A role for S1P signalling in axon guidance in the Xenopus visual system. 2008 Development pmid:18077591
Simonaro CM et al. Mechanism of glycosaminoglycan-mediated bone and joint disease: implications for the mucopolysaccharidoses and other connective tissue diseases. 2008 Am. J. Pathol. pmid:18079441
Zabielski P et al. Bezafibrate decreases growth stimulatory action of the sphingomyelin signaling pathway in regenerating rat liver. 2008 Prostaglandins Other Lipid Mediat. pmid:18024222
Landeen LK et al. Mechanisms of the negative inotropic effects of sphingosine-1-phosphate on adult mouse ventricular myocytes. 2008 Am. J. Physiol. Heart Circ. Physiol. pmid:18024550
Salomone S et al. Analysis of sphingosine 1-phosphate receptors involved in constriction of isolated cerebral arteries with receptor null mice and pharmacological tools. 2008 Br. J. Pharmacol. pmid:18026125
Ruckhäberle E et al. Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer. 2008 Breast Cancer Res. Treat. pmid:18058224
Singh IN and Hall ED Multifaceted roles of sphingosine-1-phosphate: how does this bioactive sphingolipid fit with acute neurological injury? 2008 J. Neurosci. Res. pmid:18058948
Stuebe S et al. Sphingosine-1-phosphate and endothelin-1 induce the expression of rgs16 protein in cardiac myocytes by transcriptional activation of the rgs16 gene. 2008 Naunyn Schmiedebergs Arch. Pharmacol. pmid:18046543
Ledgerwood LG et al. The sphingosine 1-phosphate receptor 1 causes tissue retention by inhibiting the entry of peripheral tissue T lymphocytes into afferent lymphatics. 2008 Nat. Immunol. pmid:18037890
Nussbaumer P et al. An efficient, one-pot synthesis of various ceramide 1-phosphates from sphingosine 1-phosphate. 2008 Chem. Phys. Lipids pmid:18039471
Srinivasan S et al. Sphingosine-1-phosphate reduces CD4+ T-cell activation in type 1 diabetes through regulation of hypoxia-inducible factor short isoform I.1 and CD69. 2008 Diabetes pmid:18003758
Johann AM et al. Apoptotic cell-derived sphingosine-1-phosphate promotes HuR-dependent cyclooxygenase-2 mRNA stabilization and protein expression. 2008 J. Immunol. pmid:18178864
Oskeritzian CA et al. Distinct roles of sphingosine kinases 1 and 2 in human mast-cell functions. 2008 Blood pmid:18178871
Lee KJ et al. Determination of sphingosine kinase activity for cellular signaling studies. 2008 Anal. Chem. pmid:18197698
Dustin ML and Chakraborty AK Tug of war at the exit door. 2008 Immunity pmid:18199414
Onions VJ et al. Ovarian tissue viability following whole ovine ovary cryopreservation: assessing the effects of sphingosine-1-phosphate inclusion. 2008 Hum. Reprod. pmid:18216042
Hannun YA and Obeid LM Principles of bioactive lipid signalling: lessons from sphingolipids. 2008 Nat. Rev. Mol. Cell Biol. pmid:18216770